Table 3.
Sham artery |
DOCA-salt artery |
|||
---|---|---|---|---|
Control (n=5) | Prazosin (n=5) | Control (n=5) | Prazosin (n=5) | |
S50 (Hz) | 5.7±0.4 | 5.9±1.0 | 5.8±0.9 | 12±2.2*# |
Emax (%) | 26±1.8 | 18±2.0& | 27±2.0 | 11±2.7*# |
Sham vein |
DOCA-salt vein |
|||
---|---|---|---|---|
Control (n=5) | Prazosin (n=5) | Control (n=5) | Prazosin (n=5) | |
S50 (Hz) | 1.5±0.6 | - | 1.9±0.5 | - |
Emax (%) | 26±2.0 | 3.5±1.0& | 23±1.5 | 5.7±2.0* |
Data are mean±S.E.M. and “n” values refer to the number of animals from which the data were obtained.
Indicates significantly different from the S50 or Emax in control sham MA (MV) (P<0.05).
Indicates significantly different from the S50 or Emax in control DOCA-saltMA (MV) (P<0.05).
Indicates significantly different from the S50 or Emax in prazosin treated sham MA (P<0.05). Data analyzed using analysis of variance and Student Newman Keuls post hoc test.